Global Prostate-Specific Antigen (PSA) Test Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Page: 104

Published Date: 02 Jan 2024

Category: Medical Care

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

According to our (Global Info Research) latest study, the global Prostate-Specific Antigen (PSA) Test market size was valued at USD 525.8 million in 2023 and is forecast to a readjusted size of USD 638.5 million by 2030 with a CAGR of 2.8% during review period.

Prostate-specific antigen (PSA), also known as gamma-seminoprotein or kallikrein-3 (KLK3), is a glycoprotein enzyme encoded in humans by the KLK3 gene.

The PSA test measures the level of PSA in a man’s blood. For this test, a blood sample is sent to a laboratory for analysis. The results are usually reported as nanograms of PSA per milliliter (ng/mL) of blood.

The major players in global PSA Test market include Abbott, Siemens Healthcare, DiaSorin, etc. The top 3 players occupy about 50% shares of the global market. North America and Europe are main markets, they occupy over 80% of the global market. CLIA is the main type, with a share over 70%. Screening is the key application, which holds a share about 80%.

The Global Info Research report includes an overview of the development of the Prostate-Specific Antigen (PSA) Test industry chain, the market status of Screening (CLIA, ELISA), Post-treatment Monitoring (CLIA, ELISA), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Prostate-Specific Antigen (PSA) Test.

Regionally, the report analyzes the Prostate-Specific Antigen (PSA) Test markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Prostate-Specific Antigen (PSA) Test market, with robust domestic demand, supportive policies, and a strong manufacturing base.

Key Features:
The report presents comprehensive understanding of the Prostate-Specific Antigen (PSA) Test market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Prostate-Specific Antigen (PSA) Test industry.

The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., CLIA, ELISA).

Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Prostate-Specific Antigen (PSA) Test market.

Regional Analysis: The report involves examining the Prostate-Specific Antigen (PSA) Test market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.

Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Prostate-Specific Antigen (PSA) Test market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.

The report also involves a more granular approach to Prostate-Specific Antigen (PSA) Test:
Company Analysis: Report covers individual Prostate-Specific Antigen (PSA) Test players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.

Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Prostate-Specific Antigen (PSA) Test This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Screening, Post-treatment Monitoring).

Technology Analysis: Report covers specific technologies relevant to Prostate-Specific Antigen (PSA) Test. It assesses the current state, advancements, and potential future developments in Prostate-Specific Antigen (PSA) Test areas.

Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Prostate-Specific Antigen (PSA) Test market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.

Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.

Market Segmentation
Prostate-Specific Antigen (PSA) Test market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.

Market segment by Type
CLIA
ELISA
Other

Market segment by Application
Screening
Post-treatment Monitoring
Other

Market segment by players, this report covers
Abbott
Siemens Healthcare
DiaSorin
Roche
Beckman Coulter
PerkinElmer
Tosoh
Ortho Clinical
Fujirebio
Mediwatch (LABORIE)
BodiTech

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Prostate-Specific Antigen (PSA) Test product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Prostate-Specific Antigen (PSA) Test, with revenue, gross margin and global market share of Prostate-Specific Antigen (PSA) Test from 2019 to 2024.
Chapter 3, the Prostate-Specific Antigen (PSA) Test competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Prostate-Specific Antigen (PSA) Test market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Prostate-Specific Antigen (PSA) Test.
Chapter 13, to describe Prostate-Specific Antigen (PSA) Test research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Prostate-Specific Antigen (PSA) Test
    1.2 Market Estimation Caveats and Base Year
    1.3 Classification of Prostate-Specific Antigen (PSA) Test by Type
        1.3.1 Overview: Global Prostate-Specific Antigen (PSA) Test Market Size by Type: 2019 Versus 2023 Versus 2030
        1.3.2 Global Prostate-Specific Antigen (PSA) Test Consumption Value Market Share by Type in 2023
        1.3.3 CLIA
        1.3.4 ELISA
        1.3.5 Other
    1.4 Global Prostate-Specific Antigen (PSA) Test Market by Application
        1.4.1 Overview: Global Prostate-Specific Antigen (PSA) Test Market Size by Application: 2019 Versus 2023 Versus 2030
        1.4.2 Screening
        1.4.3 Post-treatment Monitoring
        1.4.4 Other
    1.5 Global Prostate-Specific Antigen (PSA) Test Market Size & Forecast
    1.6 Global Prostate-Specific Antigen (PSA) Test Market Size and Forecast by Region
        1.6.1 Global Prostate-Specific Antigen (PSA) Test Market Size by Region: 2019 VS 2023 VS 2030
        1.6.2 Global Prostate-Specific Antigen (PSA) Test Market Size by Region, (2019-2030)
        1.6.3 North America Prostate-Specific Antigen (PSA) Test Market Size and Prospect (2019-2030)
        1.6.4 Europe Prostate-Specific Antigen (PSA) Test Market Size and Prospect (2019-2030)
        1.6.5 Asia-Pacific Prostate-Specific Antigen (PSA) Test Market Size and Prospect (2019-2030)
        1.6.6 South America Prostate-Specific Antigen (PSA) Test Market Size and Prospect (2019-2030)
        1.6.7 Middle East and Africa Prostate-Specific Antigen (PSA) Test Market Size and Prospect (2019-2030)

2 Company Profiles
    2.1 Abbott
        2.1.1 Abbott Details
        2.1.2 Abbott Major Business
        2.1.3 Abbott Prostate-Specific Antigen (PSA) Test Product and Solutions
        2.1.4 Abbott Prostate-Specific Antigen (PSA) Test Revenue, Gross Margin and Market Share (2019-2024)
        2.1.5 Abbott Recent Developments and Future Plans
    2.2 Siemens Healthcare
        2.2.1 Siemens Healthcare Details
        2.2.2 Siemens Healthcare Major Business
        2.2.3 Siemens Healthcare Prostate-Specific Antigen (PSA) Test Product and Solutions
        2.2.4 Siemens Healthcare Prostate-Specific Antigen (PSA) Test Revenue, Gross Margin and Market Share (2019-2024)
        2.2.5 Siemens Healthcare Recent Developments and Future Plans
    2.3 DiaSorin
        2.3.1 DiaSorin Details
        2.3.2 DiaSorin Major Business
        2.3.3 DiaSorin Prostate-Specific Antigen (PSA) Test Product and Solutions
        2.3.4 DiaSorin Prostate-Specific Antigen (PSA) Test Revenue, Gross Margin and Market Share (2019-2024)
        2.3.5 DiaSorin Recent Developments and Future Plans
    2.4 Roche
        2.4.1 Roche Details
        2.4.2 Roche Major Business
        2.4.3 Roche Prostate-Specific Antigen (PSA) Test Product and Solutions
        2.4.4 Roche Prostate-Specific Antigen (PSA) Test Revenue, Gross Margin and Market Share (2019-2024)
        2.4.5 Roche Recent Developments and Future Plans
    2.5 Beckman Coulter
        2.5.1 Beckman Coulter Details
        2.5.2 Beckman Coulter Major Business
        2.5.3 Beckman Coulter Prostate-Specific Antigen (PSA) Test Product and Solutions
        2.5.4 Beckman Coulter Prostate-Specific Antigen (PSA) Test Revenue, Gross Margin and Market Share (2019-2024)
        2.5.5 Beckman Coulter Recent Developments and Future Plans
    2.6 PerkinElmer
        2.6.1 PerkinElmer Details
        2.6.2 PerkinElmer Major Business
        2.6.3 PerkinElmer Prostate-Specific Antigen (PSA) Test Product and Solutions
        2.6.4 PerkinElmer Prostate-Specific Antigen (PSA) Test Revenue, Gross Margin and Market Share (2019-2024)
        2.6.5 PerkinElmer Recent Developments and Future Plans
    2.7 Tosoh
        2.7.1 Tosoh Details
        2.7.2 Tosoh Major Business
        2.7.3 Tosoh Prostate-Specific Antigen (PSA) Test Product and Solutions
        2.7.4 Tosoh Prostate-Specific Antigen (PSA) Test Revenue, Gross Margin and Market Share (2019-2024)
        2.7.5 Tosoh Recent Developments and Future Plans
    2.8 Ortho Clinical
        2.8.1 Ortho Clinical Details
        2.8.2 Ortho Clinical Major Business
        2.8.3 Ortho Clinical Prostate-Specific Antigen (PSA) Test Product and Solutions
        2.8.4 Ortho Clinical Prostate-Specific Antigen (PSA) Test Revenue, Gross Margin and Market Share (2019-2024)
        2.8.5 Ortho Clinical Recent Developments and Future Plans
    2.9 Fujirebio
        2.9.1 Fujirebio Details
        2.9.2 Fujirebio Major Business
        2.9.3 Fujirebio Prostate-Specific Antigen (PSA) Test Product and Solutions
        2.9.4 Fujirebio Prostate-Specific Antigen (PSA) Test Revenue, Gross Margin and Market Share (2019-2024)
        2.9.5 Fujirebio Recent Developments and Future Plans
    2.10 Mediwatch (LABORIE)
        2.10.1 Mediwatch (LABORIE) Details
        2.10.2 Mediwatch (LABORIE) Major Business
        2.10.3 Mediwatch (LABORIE) Prostate-Specific Antigen (PSA) Test Product and Solutions
        2.10.4 Mediwatch (LABORIE) Prostate-Specific Antigen (PSA) Test Revenue, Gross Margin and Market Share (2019-2024)
        2.10.5 Mediwatch (LABORIE) Recent Developments and Future Plans
    2.11 BodiTech
        2.11.1 BodiTech Details
        2.11.2 BodiTech Major Business
        2.11.3 BodiTech Prostate-Specific Antigen (PSA) Test Product and Solutions
        2.11.4 BodiTech Prostate-Specific Antigen (PSA) Test Revenue, Gross Margin and Market Share (2019-2024)
        2.11.5 BodiTech Recent Developments and Future Plans

3 Market Competition, by Players
    3.1 Global Prostate-Specific Antigen (PSA) Test Revenue and Share by Players (2019-2024)
    3.2 Market Share Analysis (2023)
        3.2.1 Market Share of Prostate-Specific Antigen (PSA) Test by Company Revenue
        3.2.2 Top 3 Prostate-Specific Antigen (PSA) Test Players Market Share in 2023
        3.2.3 Top 6 Prostate-Specific Antigen (PSA) Test Players Market Share in 2023
    3.3 Prostate-Specific Antigen (PSA) Test Market: Overall Company Footprint Analysis
        3.3.1 Prostate-Specific Antigen (PSA) Test Market: Region Footprint
        3.3.2 Prostate-Specific Antigen (PSA) Test Market: Company Product Type Footprint
        3.3.3 Prostate-Specific Antigen (PSA) Test Market: Company Product Application Footprint
    3.4 New Market Entrants and Barriers to Market Entry
    3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type
    4.1 Global Prostate-Specific Antigen (PSA) Test Consumption Value and Market Share by Type (2019-2024)
    4.2 Global Prostate-Specific Antigen (PSA) Test Market Forecast by Type (2025-2030)

5 Market Size Segment by Application
    5.1 Global Prostate-Specific Antigen (PSA) Test Consumption Value Market Share by Application (2019-2024)
    5.2 Global Prostate-Specific Antigen (PSA) Test Market Forecast by Application (2025-2030)

6 North America
    6.1 North America Prostate-Specific Antigen (PSA) Test Consumption Value by Type (2019-2030)
    6.2 North America Prostate-Specific Antigen (PSA) Test Consumption Value by Application (2019-2030)
    6.3 North America Prostate-Specific Antigen (PSA) Test Market Size by Country
        6.3.1 North America Prostate-Specific Antigen (PSA) Test Consumption Value by Country (2019-2030)
        6.3.2 United States Prostate-Specific Antigen (PSA) Test Market Size and Forecast (2019-2030)
        6.3.3 Canada Prostate-Specific Antigen (PSA) Test Market Size and Forecast (2019-2030)
        6.3.4 Mexico Prostate-Specific Antigen (PSA) Test Market Size and Forecast (2019-2030)

7 Europe
    7.1 Europe Prostate-Specific Antigen (PSA) Test Consumption Value by Type (2019-2030)
    7.2 Europe Prostate-Specific Antigen (PSA) Test Consumption Value by Application (2019-2030)
    7.3 Europe Prostate-Specific Antigen (PSA) Test Market Size by Country
        7.3.1 Europe Prostate-Specific Antigen (PSA) Test Consumption Value by Country (2019-2030)
        7.3.2 Germany Prostate-Specific Antigen (PSA) Test Market Size and Forecast (2019-2030)
        7.3.3 France Prostate-Specific Antigen (PSA) Test Market Size and Forecast (2019-2030)
        7.3.4 United Kingdom Prostate-Specific Antigen (PSA) Test Market Size and Forecast (2019-2030)
        7.3.5 Russia Prostate-Specific Antigen (PSA) Test Market Size and Forecast (2019-2030)
        7.3.6 Italy Prostate-Specific Antigen (PSA) Test Market Size and Forecast (2019-2030)

8 Asia-Pacific
    8.1 Asia-Pacific Prostate-Specific Antigen (PSA) Test Consumption Value by Type (2019-2030)
    8.2 Asia-Pacific Prostate-Specific Antigen (PSA) Test Consumption Value by Application (2019-2030)
    8.3 Asia-Pacific Prostate-Specific Antigen (PSA) Test Market Size by Region
        8.3.1 Asia-Pacific Prostate-Specific Antigen (PSA) Test Consumption Value by Region (2019-2030)
        8.3.2 China Prostate-Specific Antigen (PSA) Test Market Size and Forecast (2019-2030)
        8.3.3 Japan Prostate-Specific Antigen (PSA) Test Market Size and Forecast (2019-2030)
        8.3.4 South Korea Prostate-Specific Antigen (PSA) Test Market Size and Forecast (2019-2030)
        8.3.5 India Prostate-Specific Antigen (PSA) Test Market Size and Forecast (2019-2030)
        8.3.6 Southeast Asia Prostate-Specific Antigen (PSA) Test Market Size and Forecast (2019-2030)
        8.3.7 Australia Prostate-Specific Antigen (PSA) Test Market Size and Forecast (2019-2030)

9 South America
    9.1 South America Prostate-Specific Antigen (PSA) Test Consumption Value by Type (2019-2030)
    9.2 South America Prostate-Specific Antigen (PSA) Test Consumption Value by Application (2019-2030)
    9.3 South America Prostate-Specific Antigen (PSA) Test Market Size by Country
        9.3.1 South America Prostate-Specific Antigen (PSA) Test Consumption Value by Country (2019-2030)
        9.3.2 Brazil Prostate-Specific Antigen (PSA) Test Market Size and Forecast (2019-2030)
        9.3.3 Argentina Prostate-Specific Antigen (PSA) Test Market Size and Forecast (2019-2030)

10 Middle East & Africa
    10.1 Middle East & Africa Prostate-Specific Antigen (PSA) Test Consumption Value by Type (2019-2030)
    10.2 Middle East & Africa Prostate-Specific Antigen (PSA) Test Consumption Value by Application (2019-2030)
    10.3 Middle East & Africa Prostate-Specific Antigen (PSA) Test Market Size by Country
        10.3.1 Middle East & Africa Prostate-Specific Antigen (PSA) Test Consumption Value by Country (2019-2030)
        10.3.2 Turkey Prostate-Specific Antigen (PSA) Test Market Size and Forecast (2019-2030)
        10.3.3 Saudi Arabia Prostate-Specific Antigen (PSA) Test Market Size and Forecast (2019-2030)
        10.3.4 UAE Prostate-Specific Antigen (PSA) Test Market Size and Forecast (2019-2030)

11 Market Dynamics
    11.1 Prostate-Specific Antigen (PSA) Test Market Drivers
    11.2 Prostate-Specific Antigen (PSA) Test Market Restraints
    11.3 Prostate-Specific Antigen (PSA) Test Trends Analysis
    11.4 Porters Five Forces Analysis
        11.4.1 Threat of New Entrants
        11.4.2 Bargaining Power of Suppliers
        11.4.3 Bargaining Power of Buyers
        11.4.4 Threat of Substitutes
        11.4.5 Competitive Rivalry

12 Industry Chain Analysis
    12.1 Prostate-Specific Antigen (PSA) Test Industry Chain
    12.2 Prostate-Specific Antigen (PSA) Test Upstream Analysis
    12.3 Prostate-Specific Antigen (PSA) Test Midstream Analysis
    12.4 Prostate-Specific Antigen (PSA) Test Downstream Analysis

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology
    14.2 Research Process and Data Source
    14.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Prostate-Specific Antigen (PSA) Test Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Table 2. Global Prostate-Specific Antigen (PSA) Test Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
    Table 3. Global Prostate-Specific Antigen (PSA) Test Consumption Value by Region (2019-2024) & (USD Million)
    Table 4. Global Prostate-Specific Antigen (PSA) Test Consumption Value by Region (2025-2030) & (USD Million)
    Table 5. Abbott Company Information, Head Office, and Major Competitors
    Table 6. Abbott Major Business
    Table 7. Abbott Prostate-Specific Antigen (PSA) Test Product and Solutions
    Table 8. Abbott Prostate-Specific Antigen (PSA) Test Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 9. Abbott Recent Developments and Future Plans
    Table 10. Siemens Healthcare Company Information, Head Office, and Major Competitors
    Table 11. Siemens Healthcare Major Business
    Table 12. Siemens Healthcare Prostate-Specific Antigen (PSA) Test Product and Solutions
    Table 13. Siemens Healthcare Prostate-Specific Antigen (PSA) Test Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 14. Siemens Healthcare Recent Developments and Future Plans
    Table 15. DiaSorin Company Information, Head Office, and Major Competitors
    Table 16. DiaSorin Major Business
    Table 17. DiaSorin Prostate-Specific Antigen (PSA) Test Product and Solutions
    Table 18. DiaSorin Prostate-Specific Antigen (PSA) Test Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 19. DiaSorin Recent Developments and Future Plans
    Table 20. Roche Company Information, Head Office, and Major Competitors
    Table 21. Roche Major Business
    Table 22. Roche Prostate-Specific Antigen (PSA) Test Product and Solutions
    Table 23. Roche Prostate-Specific Antigen (PSA) Test Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 24. Roche Recent Developments and Future Plans
    Table 25. Beckman Coulter Company Information, Head Office, and Major Competitors
    Table 26. Beckman Coulter Major Business
    Table 27. Beckman Coulter Prostate-Specific Antigen (PSA) Test Product and Solutions
    Table 28. Beckman Coulter Prostate-Specific Antigen (PSA) Test Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 29. Beckman Coulter Recent Developments and Future Plans
    Table 30. PerkinElmer Company Information, Head Office, and Major Competitors
    Table 31. PerkinElmer Major Business
    Table 32. PerkinElmer Prostate-Specific Antigen (PSA) Test Product and Solutions
    Table 33. PerkinElmer Prostate-Specific Antigen (PSA) Test Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 34. PerkinElmer Recent Developments and Future Plans
    Table 35. Tosoh Company Information, Head Office, and Major Competitors
    Table 36. Tosoh Major Business
    Table 37. Tosoh Prostate-Specific Antigen (PSA) Test Product and Solutions
    Table 38. Tosoh Prostate-Specific Antigen (PSA) Test Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 39. Tosoh Recent Developments and Future Plans
    Table 40. Ortho Clinical Company Information, Head Office, and Major Competitors
    Table 41. Ortho Clinical Major Business
    Table 42. Ortho Clinical Prostate-Specific Antigen (PSA) Test Product and Solutions
    Table 43. Ortho Clinical Prostate-Specific Antigen (PSA) Test Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 44. Ortho Clinical Recent Developments and Future Plans
    Table 45. Fujirebio Company Information, Head Office, and Major Competitors
    Table 46. Fujirebio Major Business
    Table 47. Fujirebio Prostate-Specific Antigen (PSA) Test Product and Solutions
    Table 48. Fujirebio Prostate-Specific Antigen (PSA) Test Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 49. Fujirebio Recent Developments and Future Plans
    Table 50. Mediwatch (LABORIE) Company Information, Head Office, and Major Competitors
    Table 51. Mediwatch (LABORIE) Major Business
    Table 52. Mediwatch (LABORIE) Prostate-Specific Antigen (PSA) Test Product and Solutions
    Table 53. Mediwatch (LABORIE) Prostate-Specific Antigen (PSA) Test Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 54. Mediwatch (LABORIE) Recent Developments and Future Plans
    Table 55. BodiTech Company Information, Head Office, and Major Competitors
    Table 56. BodiTech Major Business
    Table 57. BodiTech Prostate-Specific Antigen (PSA) Test Product and Solutions
    Table 58. BodiTech Prostate-Specific Antigen (PSA) Test Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 59. BodiTech Recent Developments and Future Plans
    Table 60. Global Prostate-Specific Antigen (PSA) Test Revenue (USD Million) by Players (2019-2024)
    Table 61. Global Prostate-Specific Antigen (PSA) Test Revenue Share by Players (2019-2024)
    Table 62. Breakdown of Prostate-Specific Antigen (PSA) Test by Company Type (Tier 1, Tier 2, and Tier 3)
    Table 63. Market Position of Players in Prostate-Specific Antigen (PSA) Test, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
    Table 64. Head Office of Key Prostate-Specific Antigen (PSA) Test Players
    Table 65. Prostate-Specific Antigen (PSA) Test Market: Company Product Type Footprint
    Table 66. Prostate-Specific Antigen (PSA) Test Market: Company Product Application Footprint
    Table 67. Prostate-Specific Antigen (PSA) Test New Market Entrants and Barriers to Market Entry
    Table 68. Prostate-Specific Antigen (PSA) Test Mergers, Acquisition, Agreements, and Collaborations
    Table 69. Global Prostate-Specific Antigen (PSA) Test Consumption Value (USD Million) by Type (2019-2024)
    Table 70. Global Prostate-Specific Antigen (PSA) Test Consumption Value Share by Type (2019-2024)
    Table 71. Global Prostate-Specific Antigen (PSA) Test Consumption Value Forecast by Type (2025-2030)
    Table 72. Global Prostate-Specific Antigen (PSA) Test Consumption Value by Application (2019-2024)
    Table 73. Global Prostate-Specific Antigen (PSA) Test Consumption Value Forecast by Application (2025-2030)
    Table 74. North America Prostate-Specific Antigen (PSA) Test Consumption Value by Type (2019-2024) & (USD Million)
    Table 75. North America Prostate-Specific Antigen (PSA) Test Consumption Value by Type (2025-2030) & (USD Million)
    Table 76. North America Prostate-Specific Antigen (PSA) Test Consumption Value by Application (2019-2024) & (USD Million)
    Table 77. North America Prostate-Specific Antigen (PSA) Test Consumption Value by Application (2025-2030) & (USD Million)
    Table 78. North America Prostate-Specific Antigen (PSA) Test Consumption Value by Country (2019-2024) & (USD Million)
    Table 79. North America Prostate-Specific Antigen (PSA) Test Consumption Value by Country (2025-2030) & (USD Million)
    Table 80. Europe Prostate-Specific Antigen (PSA) Test Consumption Value by Type (2019-2024) & (USD Million)
    Table 81. Europe Prostate-Specific Antigen (PSA) Test Consumption Value by Type (2025-2030) & (USD Million)
    Table 82. Europe Prostate-Specific Antigen (PSA) Test Consumption Value by Application (2019-2024) & (USD Million)
    Table 83. Europe Prostate-Specific Antigen (PSA) Test Consumption Value by Application (2025-2030) & (USD Million)
    Table 84. Europe Prostate-Specific Antigen (PSA) Test Consumption Value by Country (2019-2024) & (USD Million)
    Table 85. Europe Prostate-Specific Antigen (PSA) Test Consumption Value by Country (2025-2030) & (USD Million)
    Table 86. Asia-Pacific Prostate-Specific Antigen (PSA) Test Consumption Value by Type (2019-2024) & (USD Million)
    Table 87. Asia-Pacific Prostate-Specific Antigen (PSA) Test Consumption Value by Type (2025-2030) & (USD Million)
    Table 88. Asia-Pacific Prostate-Specific Antigen (PSA) Test Consumption Value by Application (2019-2024) & (USD Million)
    Table 89. Asia-Pacific Prostate-Specific Antigen (PSA) Test Consumption Value by Application (2025-2030) & (USD Million)
    Table 90. Asia-Pacific Prostate-Specific Antigen (PSA) Test Consumption Value by Region (2019-2024) & (USD Million)
    Table 91. Asia-Pacific Prostate-Specific Antigen (PSA) Test Consumption Value by Region (2025-2030) & (USD Million)
    Table 92. South America Prostate-Specific Antigen (PSA) Test Consumption Value by Type (2019-2024) & (USD Million)
    Table 93. South America Prostate-Specific Antigen (PSA) Test Consumption Value by Type (2025-2030) & (USD Million)
    Table 94. South America Prostate-Specific Antigen (PSA) Test Consumption Value by Application (2019-2024) & (USD Million)
    Table 95. South America Prostate-Specific Antigen (PSA) Test Consumption Value by Application (2025-2030) & (USD Million)
    Table 96. South America Prostate-Specific Antigen (PSA) Test Consumption Value by Country (2019-2024) & (USD Million)
    Table 97. South America Prostate-Specific Antigen (PSA) Test Consumption Value by Country (2025-2030) & (USD Million)
    Table 98. Middle East & Africa Prostate-Specific Antigen (PSA) Test Consumption Value by Type (2019-2024) & (USD Million)
    Table 99. Middle East & Africa Prostate-Specific Antigen (PSA) Test Consumption Value by Type (2025-2030) & (USD Million)
    Table 100. Middle East & Africa Prostate-Specific Antigen (PSA) Test Consumption Value by Application (2019-2024) & (USD Million)
    Table 101. Middle East & Africa Prostate-Specific Antigen (PSA) Test Consumption Value by Application (2025-2030) & (USD Million)
    Table 102. Middle East & Africa Prostate-Specific Antigen (PSA) Test Consumption Value by Country (2019-2024) & (USD Million)
    Table 103. Middle East & Africa Prostate-Specific Antigen (PSA) Test Consumption Value by Country (2025-2030) & (USD Million)
    Table 104. Prostate-Specific Antigen (PSA) Test Raw Material
    Table 105. Key Suppliers of Prostate-Specific Antigen (PSA) Test Raw Materials
List of Figures
    Figure 1. Prostate-Specific Antigen (PSA) Test Picture
    Figure 2. Global Prostate-Specific Antigen (PSA) Test Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Figure 3. Global Prostate-Specific Antigen (PSA) Test Consumption Value Market Share by Type in 2023
    Figure 4. CLIA
    Figure 5. ELISA
    Figure 6. Other
    Figure 7. Global Prostate-Specific Antigen (PSA) Test Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Figure 8. Prostate-Specific Antigen (PSA) Test Consumption Value Market Share by Application in 2023
    Figure 9. Screening Picture
    Figure 10. Post-treatment Monitoring Picture
    Figure 11. Other Picture
    Figure 12. Global Prostate-Specific Antigen (PSA) Test Consumption Value, (USD Million): 2019 & 2023 & 2030
    Figure 13. Global Prostate-Specific Antigen (PSA) Test Consumption Value and Forecast (2019-2030) & (USD Million)
    Figure 14. Global Market Prostate-Specific Antigen (PSA) Test Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
    Figure 15. Global Prostate-Specific Antigen (PSA) Test Consumption Value Market Share by Region (2019-2030)
    Figure 16. Global Prostate-Specific Antigen (PSA) Test Consumption Value Market Share by Region in 2023
    Figure 17. North America Prostate-Specific Antigen (PSA) Test Consumption Value (2019-2030) & (USD Million)
    Figure 18. Europe Prostate-Specific Antigen (PSA) Test Consumption Value (2019-2030) & (USD Million)
    Figure 19. Asia-Pacific Prostate-Specific Antigen (PSA) Test Consumption Value (2019-2030) & (USD Million)
    Figure 20. South America Prostate-Specific Antigen (PSA) Test Consumption Value (2019-2030) & (USD Million)
    Figure 21. Middle East and Africa Prostate-Specific Antigen (PSA) Test Consumption Value (2019-2030) & (USD Million)
    Figure 22. Global Prostate-Specific Antigen (PSA) Test Revenue Share by Players in 2023
    Figure 23. Prostate-Specific Antigen (PSA) Test Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
    Figure 24. Global Top 3 Players Prostate-Specific Antigen (PSA) Test Market Share in 2023
    Figure 25. Global Top 6 Players Prostate-Specific Antigen (PSA) Test Market Share in 2023
    Figure 26. Global Prostate-Specific Antigen (PSA) Test Consumption Value Share by Type (2019-2024)
    Figure 27. Global Prostate-Specific Antigen (PSA) Test Market Share Forecast by Type (2025-2030)
    Figure 28. Global Prostate-Specific Antigen (PSA) Test Consumption Value Share by Application (2019-2024)
    Figure 29. Global Prostate-Specific Antigen (PSA) Test Market Share Forecast by Application (2025-2030)
    Figure 30. North America Prostate-Specific Antigen (PSA) Test Consumption Value Market Share by Type (2019-2030)
    Figure 31. North America Prostate-Specific Antigen (PSA) Test Consumption Value Market Share by Application (2019-2030)
    Figure 32. North America Prostate-Specific Antigen (PSA) Test Consumption Value Market Share by Country (2019-2030)
    Figure 33. United States Prostate-Specific Antigen (PSA) Test Consumption Value (2019-2030) & (USD Million)
    Figure 34. Canada Prostate-Specific Antigen (PSA) Test Consumption Value (2019-2030) & (USD Million)
    Figure 35. Mexico Prostate-Specific Antigen (PSA) Test Consumption Value (2019-2030) & (USD Million)
    Figure 36. Europe Prostate-Specific Antigen (PSA) Test Consumption Value Market Share by Type (2019-2030)
    Figure 37. Europe Prostate-Specific Antigen (PSA) Test Consumption Value Market Share by Application (2019-2030)
    Figure 38. Europe Prostate-Specific Antigen (PSA) Test Consumption Value Market Share by Country (2019-2030)
    Figure 39. Germany Prostate-Specific Antigen (PSA) Test Consumption Value (2019-2030) & (USD Million)
    Figure 40. France Prostate-Specific Antigen (PSA) Test Consumption Value (2019-2030) & (USD Million)
    Figure 41. United Kingdom Prostate-Specific Antigen (PSA) Test Consumption Value (2019-2030) & (USD Million)
    Figure 42. Russia Prostate-Specific Antigen (PSA) Test Consumption Value (2019-2030) & (USD Million)
    Figure 43. Italy Prostate-Specific Antigen (PSA) Test Consumption Value (2019-2030) & (USD Million)
    Figure 44. Asia-Pacific Prostate-Specific Antigen (PSA) Test Consumption Value Market Share by Type (2019-2030)
    Figure 45. Asia-Pacific Prostate-Specific Antigen (PSA) Test Consumption Value Market Share by Application (2019-2030)
    Figure 46. Asia-Pacific Prostate-Specific Antigen (PSA) Test Consumption Value Market Share by Region (2019-2030)
    Figure 47. China Prostate-Specific Antigen (PSA) Test Consumption Value (2019-2030) & (USD Million)
    Figure 48. Japan Prostate-Specific Antigen (PSA) Test Consumption Value (2019-2030) & (USD Million)
    Figure 49. South Korea Prostate-Specific Antigen (PSA) Test Consumption Value (2019-2030) & (USD Million)
    Figure 50. India Prostate-Specific Antigen (PSA) Test Consumption Value (2019-2030) & (USD Million)
    Figure 51. Southeast Asia Prostate-Specific Antigen (PSA) Test Consumption Value (2019-2030) & (USD Million)
    Figure 52. Australia Prostate-Specific Antigen (PSA) Test Consumption Value (2019-2030) & (USD Million)
    Figure 53. South America Prostate-Specific Antigen (PSA) Test Consumption Value Market Share by Type (2019-2030)
    Figure 54. South America Prostate-Specific Antigen (PSA) Test Consumption Value Market Share by Application (2019-2030)
    Figure 55. South America Prostate-Specific Antigen (PSA) Test Consumption Value Market Share by Country (2019-2030)
    Figure 56. Brazil Prostate-Specific Antigen (PSA) Test Consumption Value (2019-2030) & (USD Million)
    Figure 57. Argentina Prostate-Specific Antigen (PSA) Test Consumption Value (2019-2030) & (USD Million)
    Figure 58. Middle East and Africa Prostate-Specific Antigen (PSA) Test Consumption Value Market Share by Type (2019-2030)
    Figure 59. Middle East and Africa Prostate-Specific Antigen (PSA) Test Consumption Value Market Share by Application (2019-2030)
    Figure 60. Middle East and Africa Prostate-Specific Antigen (PSA) Test Consumption Value Market Share by Country (2019-2030)
    Figure 61. Turkey Prostate-Specific Antigen (PSA) Test Consumption Value (2019-2030) & (USD Million)
    Figure 62. Saudi Arabia Prostate-Specific Antigen (PSA) Test Consumption Value (2019-2030) & (USD Million)
    Figure 63. UAE Prostate-Specific Antigen (PSA) Test Consumption Value (2019-2030) & (USD Million)
    Figure 64. Prostate-Specific Antigen (PSA) Test Market Drivers
    Figure 65. Prostate-Specific Antigen (PSA) Test Market Restraints
    Figure 66. Prostate-Specific Antigen (PSA) Test Market Trends
    Figure 67. Porters Five Forces Analysis
    Figure 68. Manufacturing Cost Structure Analysis of Prostate-Specific Antigen (PSA) Test in 2023
    Figure 69. Manufacturing Process Analysis of Prostate-Specific Antigen (PSA) Test
    Figure 70. Prostate-Specific Antigen (PSA) Test Industrial Chain
    Figure 71. Methodology
    Figure 72. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Abbott
Siemens Healthcare
DiaSorin
Roche
Beckman Coulter
PerkinElmer
Tosoh
Ortho Clinical
Fujirebio
Mediwatch (LABORIE)
BodiTech

Related Reports

Global Prostate-Specific Antigen (PSA) Test Supply, Demand and Key Producers, 2023-2029

Global Prostate-Specific Antigen (PSA) Test Supply, Demand and Key Producers, 2023-2029

date 26 Feb 2023

date Medical Care

Prostate-specific antigen (PSA), also known as gamma-seminoprotein or kallikrein-3 (KLK3), is a glycoprotein enzyme encoded in humans by the KLK3 gene.

Product Tags

Prostate-Specific Antigen (PSA) Test

Organ Rejection Prophylaxis Treatment

Biologics Analytical Services

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>